These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25653862)

  • 41. Management of HCV-related end-stage liver disease in HIV-coinfected patients.
    Merchante N; Jiménez-Saenz M; Pineda JA
    AIDS Rev; 2007; 9(3):131-9. PubMed ID: 17982938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results.
    Martin M; Zajko AB; Orons PD; Dodd G; Wright H; Colangelo J; Tartar R
    Surgery; 1993 Oct; 114(4):719-26; discussion 726-7. PubMed ID: 8211686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
    Lo GH; Lam HC; Cheng JT; Lin JK; Hsu JH; Lai KH; Chiang HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):596-602. PubMed ID: 9830237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analyse related factors of impact and prognosis of 73 cases of severe hepatitis].
    Zhao JM; Zhang L; Du QW; Mu CQ; Ren YL; Hu LP; Shen G; Zhuang LW; Lu Y; Qiu GH; Sun QF; Wu YZ; Yang M; Li MH; Xie Y; Cheng J; Xu DZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):366-9. PubMed ID: 24645325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of spontaneous bleeding due to hepatocellular carcinoma.
    Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N
    Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changing aspects of cirrhotic disease in a hepato-gastroenterology service in Mali].
    Diarra M; Konaté A; Soukho A; Dicko M; Kallé A; Doumbia K; Sow H; Traoré HA; Maiga MY
    Mali Med; 2010; 25(1):42-6. PubMed ID: 21436002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Major complications of acute and chronic liver disease.
    Munoz SJ; Maddrey WC
    Gastroenterol Clin North Am; 1988 Jun; 17(2):265-87. PubMed ID: 3049345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical illness-related corticosteroid insufficiency in cirrhotic patients with acute gastroesophageal variceal bleeding: risk factors and association with outcome*.
    Tsai MH; Huang HC; Peng YS; Chen YC; Tian YC; Yang CW; Lien JM; Fang JT; Wu CS; Lee FY
    Crit Care Med; 2014 Dec; 42(12):2546-55. PubMed ID: 25083978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Management of ascites due to portal hypertension].
    Godat S; Antonino AT; Dehlavi MA; Moradpour D; Doerig C
    Rev Med Suisse; 2012 Sep; 8(352):1665-8. PubMed ID: 22988726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrahepatic portosystemic shunt in treatment of complications of portal hypertension.
    Wróblewski T; Rowiński O; Pawlak J; Małkowski P; Ziarkiewicz-Wróblewska B; Michałowicz B; Zurakowski J; Krawczyk M
    Med Sci Monit; 2001 May; 7 Suppl 1():305-10. PubMed ID: 12211743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indications for liver transplantation.
    O'Leary JG; Lepe R; Davis GL
    Gastroenterology; 2008 May; 134(6):1764-76. PubMed ID: 18471553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cirrhosis complications: keeping them under control.
    Minor SE; Eliacin I; Kashan S; Whisenant EB
    J Fam Pract; 2015 Jun; 64(6):338-42. PubMed ID: 26172625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
    Karwa R; Woodis CB
    Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Care of the cirrhotic patient.
    Grewal P; Martin P
    Clin Liver Dis; 2009 May; 13(2):331-40. PubMed ID: 19442922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C; López-Balaguer JM; Aracil C; Kolle L; González B; Miñana J; Soriano G; Guarner C; Balanzó J
    J Hepatol; 2004 May; 40(5):757-65. PubMed ID: 15094222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sclerotherapy on liver cirrhosis with esophageal variceal bleeding: eight years of experience.
    Cheng CY; Chen GH; Chang CS; Tseng CC; Chen TY; Lin CK; Pan HK; Huang CK; Hsieh PF; Huang PT
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):321-8. PubMed ID: 7834554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ascites in cirrhosis: a review of management and complications.
    Kuiper JJ; van Buuren HR; de Man RA
    Neth J Med; 2007 Sep; 65(8):283-8. PubMed ID: 17890787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical Care of the Patient With Compensated Cirrhosis.
    Herrera JL; Rodríguez R
    Gastroenterol Hepatol (N Y); 2006 Feb; 2(2):124-133. PubMed ID: 28286440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.